Pune-based Emcure Pharmaceuticals has pulled out its proposed red herring prospectus or DRHP with securities market regulator SEBI. Emcure Pharmaceuticals on Wednesday said it has filed a draft red herring prospectus (DRHP) with the Sebi for launching an initial public offer. Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus ( DRHP) with SEBI for initial public offering that includes fresh issue.
|Published (Last):||9 September 2013|
|PDF File Size:||11.58 Mb|
|ePub File Size:||1.97 Mb|
|Price:||Free* [*Free Regsitration Required]|
Leave Your Comment s. Jul 03, Link Intime India Private Limited is a registrar to the issue. Book running lead managers to the issue include Bank of America Merrill Lynch.
Antibiotics made by Emcure Pharmaceuticals recalled in US.
For the nine months ended December 31,Emcure’s revenue from operations was Rs 1, crore with net profit at Rs Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus DRHP with SEBI for initial public offering that includes fresh issue of upto Rs crore and an offer for sale of upto 25,13, equity share. Fill in your details: Blackstone Emcure Bain Capital private equity stake. The company commercialises its products through a combination of its own marketing and distribution infrastructure.
Bain Capital has paid nearly Rs. My Saved Articles Sign in Sign up.
Emcure Pharmaceuticals files IPO papers with SEBI
These areas include cardiology, pain and analgesics, Ddrhp, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients. For the nine months period ended December We have not given a thought to a pre-IPO funding round. Blackstone has exited now. The issue also involves a secondary sale 2. It is ranked as the 7th-largest pharmaceutical company in the therapeutic areas in which it operates. This will alert our moderators to take action.
Emcure Pharmaceuticals withdraws proposed IPO | VCCircle
Your Reason has been Reported to the admin. These areas include cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients.
Warren Buffett has this piece of advice for youngsters and it’s not stocks. Crude oil prices to direct sugar prices in Reliance to buy majority stake in renewable energy services firm Kanoda.
Log in Keep me signed in. Will be displayed Will not be displayed Will be displayed. Another pharmaceutical firm which filed for public offering recently was Intas Pharmaceuticals. Get instant notifications from Economic Times Allow Not now.
Emcure Pharmaceuticals withdraws proposed IPO
Mandhana added that while an IPO is a convenient route for exits, secondary transactions provide more comfort to the new investor as potential corporate governance issues would have already been taken care of by the exiting PE emvure. Emcure Pharmaceuticals withdraws proposed IPO. This follows a deal struck late last year where Blackstone sold its stake to Bain Capital for an undisclosed amount. Will the government be able to play Emcure Pharmaceuticals withdraws proposed IPO.
Sensex finishes year above 36, posts third straight annual gain. Foul language Slanderous Inciting hatred against a certain community Others. Here’s how the world is celebrating Christmas.
Emcure Pharmaceuticals files DRHP for IPO – The Economic Times
The Thomson Reuters Trust Principles. Emcure Pharmaceuticals acquires Canadian company and emckre marketing arm Marcan.
Blackstone had invested Rs crore in Emcure through convertible shares and held Private equity major Blackstone has started the process of exiting its maiden investment in India, Emcure Pharmaceuticals. Choose your reason ddhp and click on the Report button. Interestingly, all the firms which decided not to go ahead with public floats are backed by private equity investors. Fri, Dec 20 It has subsidiaries in Brazil, DubaiNigeria, Singapore and South Africa and branch offices in Morocco and Russiawhich play an important role in its international operations, the release said.